Accelerated Cure Project Policy

Policy on Accepting Financial Support

The Accelerated Cure Project's mission is to cure Multiple Sclerosis. Financial support is both necessary and welcome, and will be used exclusively to further our efforts. Accelerated Cure Project is glad to accept support from organizations who serve individuals with Multiple Sclerosis, although to protect our impartiality, we will not serve as a venue for these organizations to promote their products or services, we will not actively endorse their products, nor will we give exclusive rights of support to them. We will publicly thank or advertise all contributors (corporate or individual) who allow us to do so.

Policy on Sharing Mailing List Information

The Accelerated Cure Project does not share your address, email or other information with other organizations without your permission. On occasion, we come across opportunities from other organizations that we feel are of interest to individuals on our mailing list. In these cases we will contact you ourselves regarding the opportunity, making it clear what our relationship is to them. Under other circumstances, we may ask if you wish to join a new list that may be shared with another organization. If this is the case it will be made clear at that point. You are free to request to be removed from our contact lists at any point. You may contact us here to be removed or update your information.

Policy on US Mail Solicitations

The Accelerated Cure Project appreciates how annoying it can be to receive repetitive mailings from a single organization seeking contributions. As such, you will receive a contribution request via US mail from us only once every six months, or no sooner than nine months after your last contribution. We do send out email appeals more frequently and we include a contribution envelope in most of our non-appeal mailings, but we assume that these more passive requests are not as intrusive.

Policy on Indirect Cost Rate

The Accelerated Cure Project funds research relevant to determining the causes of Multiple Sclerosis. Awards are made to institutions on the behalf of individual investigators. The indirect cost rate is 10% of direct costs.